174 related articles for article (PubMed ID: 15975684)
1. Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
Mutimer D
J Hepatol; 2005 Aug; 43(2):200-2. PubMed ID: 15975684
[No Abstract] [Full Text] [Related]
2. Hepatitis B virus kinetics and mathematical modeling.
Perelson AS; Ribeiro RM
Semin Liver Dis; 2004; 24 Suppl 1():11-6. PubMed ID: 15192796
[TBL] [Abstract][Full Text] [Related]
3. Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir-lamivudine combination therapy.
Mihm U; Gärtner BC; Faust D; Hofmann WP; Sarrazin C; Zeuzem S; Herrmann E
J Hepatol; 2005 Aug; 43(2):217-24. PubMed ID: 15964093
[TBL] [Abstract][Full Text] [Related]
4. Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
Kuwahara R; Kumashiro R; Inoue H; Tanabe R; Tanaka E; Hino T; Ide T; Koga Y; Sata M
Dig Dis Sci; 2004 Feb; 49(2):300-3. PubMed ID: 15104374
[No Abstract] [Full Text] [Related]
5. [New antiviral agent. Hepatitis B therapy with slight resistance risk].
MMW Fortschr Med; 2003 Dec; 145(51-52):40. PubMed ID: 14974332
[No Abstract] [Full Text] [Related]
6. Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
Taltavull TC; Chahri N; Verdura B; Gornals J; Lopez C; Casanova A; Cañas C; Figueras J; Casais LA
Transpl Int; 2005 Jul; 18(7):879-83. PubMed ID: 15948869
[TBL] [Abstract][Full Text] [Related]
7. A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil.
Bozdayi AM; Eyigun CP; Turkyilmaz AR; Avci IY; Pahsa A; Yurdaydin C
J Clin Virol; 2004 Sep; 31(1):76-7. PubMed ID: 15288618
[No Abstract] [Full Text] [Related]
8. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.
Lampertico P; Viganò M; Manenti E; Iavarone M; Lunghi G; Colombo M
Hepatology; 2005 Dec; 42(6):1414-9. PubMed ID: 16317671
[TBL] [Abstract][Full Text] [Related]
9. Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: is adefovir dipivoxil the answer?
Thio CL
J Hepatol; 2006 Jan; 44(1):1-3. PubMed ID: 16293338
[No Abstract] [Full Text] [Related]
10. Treatment of patients with chronic hepatitis B with adefovir dipivoxil.
Tong MJ; Tu SS
Semin Liver Dis; 2004; 24 Suppl 1():37-44. PubMed ID: 15192800
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Van Bömmel F; Schernick A; Hopf U; Berg T
Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
[No Abstract] [Full Text] [Related]
12. Controversies about the treatment of hepatitis B (lamivudine, interferon, a combination or more?).
Desai HG; Chowdhury A
Trop Gastroenterol; 2003; 24(3):157-60. PubMed ID: 14978995
[No Abstract] [Full Text] [Related]
13. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
Wiegand J; Tischendorf JJ; Nashan B; Klempnauer J; Flemming P; Niemann P; Rohde P; Manns MP; Trautwein C; Tillmann HL
Z Gastroenterol; 2004 Jan; 42(1):15-8. PubMed ID: 14997399
[TBL] [Abstract][Full Text] [Related]
14. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
Enomoto M; Nishiguchi S; Seki S; Yamane T; Hino M
Am J Gastroenterol; 2004 Aug; 99(8):1619-20. PubMed ID: 15307884
[No Abstract] [Full Text] [Related]
15. Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B.
Marcellin P; Asselah T
J Hepatol; 2005 Dec; 43(6):920-3. PubMed ID: 16246449
[No Abstract] [Full Text] [Related]
16. [Current treatment of hepatitis B].
Suárez García E; Romero Gómez M; Grande Santamaría L
Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
[No Abstract] [Full Text] [Related]
17. Viral hepatitis B.
Lai CL; Ratziu V; Yuen MF; Poynard T
Lancet; 2003 Dec; 362(9401):2089-94. PubMed ID: 14697813
[TBL] [Abstract][Full Text] [Related]
18. Early detection of hepatitis B drug resistance: implications for patient management.
Sablon E; Shapiro F; Zoulim F
Expert Rev Mol Diagn; 2003 Sep; 3(5):535-47. PubMed ID: 14510175
[TBL] [Abstract][Full Text] [Related]
19. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.
Bárcena R; Del Campo S; Moraleda G; Casanovas T; Prieto M; Buti M; Moreno JM; Cuervas V; Fraga E; De la Mata M; Otero A; Delgado M; Loinaz C; Barrios C; Dieguez ML; Mas A; Sousa JM; Herrero JI; Muñoz R; Avilés JF; Gonzalez A; Rueda M
Transplant Proc; 2005 Nov; 37(9):3960-2. PubMed ID: 16386596
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy for chronic hepatitis B.
Schalm SW
J Hepatol; 2003; 39 Suppl 1():S146-50. PubMed ID: 14708694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
